Production (Stage)
E
Bright Minds Biosciences Inc. DRUG
CNSX
Recommendation
Prev Close
$38.83
Volume
--
Avg Vol (90D)
520
Market Cap
$202.53M
Dividend & Yield
--
52-Week Range
$1.30 - $108.00
P/E (TTM)
--
EPS (TTM)
-$0.3761
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Biotechs on the Brink: 2 Stocks With Huge Potential
2/14/2025 - MarketBeat
Bright Minds Biosciences (DRUG, $28.24) entered Downtrend as Momentum indicator drops below 0 level on Jun 16, 2025
6/17/2025 - Tickeron - Stocks
Bright Minds Biosciences (DRUG, $28.27) entered Uptrend as Momentum indicator ascends above 0 level on Jun 10, 2025
6/11/2025 - Tickeron - Stocks
Bright Minds Biosciences (DRUG, $28.27) Moving Average Convergence Divergence (MACD) Histogram turned positive on June 10, 2025
6/11/2025 - Tickeron - Stocks
DRUG FY2025 EPS Forecast Increased by Cantor Fitzgerald
6/11/2025 - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) versus SCYNEXIS (NASDAQ:SCYX) Financial Analysis
6/11/2025 - Ticker Report
Bright Minds Biosciences (DRUG, $28.32) RSI Indicator left the oversold zone on June 02, 2025
6/3/2025 - Tickeron - Stocks
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Buy" from Analysts
6/1/2025 - MarketBeat
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
5/28/2025 - GuruFocus
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
5/28/2025 - Globe Newswire
What is Chardan Capital's Forecast for DRUG FY2025 Earnings?
5/27/2025 - MarketBeat
HC Wainwright Issues Pessimistic Outlook for DRUG Earnings
5/27/2025 - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Cut to "Sell" at Wall Street Zen
5/24/2025 - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Rating Lowered to "Sell" at Wall Street Zen
5/24/2025 - Ticker Report
Chardan Capital Reiterates Buy Rating for Bright Minds Biosciences (NASDAQ:DRUG)
5/23/2025 - MarketBeat
Bright Minds Biosciences (DRUG, $30.22) entered Downtrend as Momentum indicator drops below 0 level on May 22, 2025
5/23/2025 - Tickeron - Stocks
Point72 Asset Management L.P. Buys Shares of 135,189 Bright Minds Biosciences Inc. (NASDAQ:DRUG)
5/22/2025 - MarketBeat
Bright Minds Biosciences (DRUG) Receives Consistent 'Buy' Rating from Chardan Capital DRUG ...
5/21/2025 - GuruFocus
Bright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
5/20/2025 - TipRanks Financial Blog
Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D ...
5/20/2025 - GuruFocus
Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025
5/20/2025 - Globe Newswire
Bright Minds Biosciences (DRUG) to Release Earnings on Wednesday
5/16/2025 - MarketBeat
TD Cowen Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG)
5/15/2025 - MarketBeat
Bright Minds Biosciences Reports Promising Results for Epilepsy Treatment
5/13/2025 - TipRanks Financial Blog
TD Cowen Initiates Coverage on Bright Minds Biosciences (DRUG) with Buy Rating DRUG Stock News
5/13/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$3.77M
Net Income (TTM)
-$2.41M
Balance Sheet
Total Assets (Q)
$39.29M
Total Debt (Q)
$115.90K
Total Liabilities (Q)
$505.70K
Book Value Per Share (Q)
$5.48
Cash Flow
Cash from Operations (TTM)
-$2.92M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$37.30M
Net Change in Cash (TTM)
$35.57M
Filings
Filing Date
Thursday, May 15, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
-4.72
7-Day Total Return
1.24%
30-Day Total Return
-13.00%
60-Day Total Return
-21.72%
90-Day Total Return
-30.27%
Year to Date Total Return
-37.26%
1-Year Total Return
2,713.97%
2-Year Total Return
920.53%
3-Year Total Return
554.19%
5-Year Total Return
--
52-week Low
Aug 28, 2024 - $1.30
52-week High
Oct 18, 2024 - $108.00
Valuation
Market Cap
$202.53M - Micro Cap
Enterprise Value
$161.65M
Price/Sales (TTM)
--
Price/Book (Q)
7.09
Dividends and Shares
Shares Outstanding
7.04M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
brightmindsbio.com
Phone Number
647 865 8622
Address
19 Vestry Street
New York, NY 10013
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of... more